Ashwin Shahir
Impact in
- Oncology top 10%
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
-
- Sarcoma Diagnosis and Treatment
- Advanced Breast Cancer Therapies
Papers in
-
- Advanced Breast Cancer Therapies 10
- Sarcoma Diagnosis and Treatment 7
- Oncology 16
- Vascular Tumors and Angiosarcomas 7
- Lung Cancer Research Studies 4
- HER2/EGFR in Cancer Research 3
- Co-authors
- Robin L. Jones (7 shared papers)William D. Tap (7 shared papers)Robert Ilaria (7 shared papers)Brian A. Van Tine (7 shared papers)Jan Cosaert (3 shared papers)Amy Qin (4 shared papers)Mark Agulnik (4 shared papers)Anthony Elias (3 shared papers)
- Journals
- Annals of Oncology (5 papers)Journal of Clinical Oncology (3 papers)Cancer Medicine (2 papers)The Breast (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Ashwin Shahir
26 papers receiving 664 citations
Ashwin Shahir's Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 400
- Pulmonary and Respiratory Medicine 476
- Cardiology and Cardiovascular Medicine 172
- Cancer Research 85
- Pathology and Forensic Medicine 101
Countries citing papers authored by Ashwin Shahir
This map shows the geographic impact of Ashwin Shahir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin Shahir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin Shahir more than expected).
Fields of papers citing papers by Ashwin Shahir
This network shows the impact of papers produced by Ashwin Shahir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin Shahir. The network helps show where Ashwin Shahir may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashwin Shahir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial Hit paper breakdown → | 2016 | 436 |
| 2 | 2019 | 46 | |
| 3 | 2021 | 31 | |
| 4 | 2018 | 26 | |
| 5 | 2009 | 16 | |
| 6 | 2015 | 14 | |
| 7 | 2017 | 13 | |
| 8 | 2024 | 12 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 11 | |
| 11 | 2018 | 10 | |
| 12 | 2017 | 9 | |
| 13 | 2011 | 9 | |
| 14 | 2023 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2021 | 2 | |
| 19 | 2019 | 2 | |
| 20 | 2016 | 2 |
About Ashwin Shahir
Ashwin Shahir is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Surgery, having authored 26 papers that have together received 677 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (10 papers), Vascular Tumors and Angiosarcomas (7 papers), Sarcoma Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Cardiac tumors and thrombi (3 papers), Breast Cancer Treatment Studies (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Oncology (400 citations), Pulmonary and Respiratory Medicine (476 citations), Cardiology and Cardiovascular Medicine (172 citations), Cancer Research (85 citations) and Pathology and Forensic Medicine (101 citations). Ashwin Shahir has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Robin L. Jones, William D. Tap, Robert Ilaria, Brian A. Van Tine, Jan Cosaert, Amy Qin, Mark Agulnik, Anthony Elias, Matthew M. Cooney and Damien M. Cronier. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Medicine, The Breast and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.